The New Federal Crackdown on 7OH
We’ve been writing about 7-hydroxymitragynine, better known as 7OH, 7-OHMG, and 7-HMG. since it first started showing up in our clients over a year ago. We warned that these drugs, which have been easily available at gas stations, vape shops, and online stores, have opioid effects, including similar highs, quick tolerance, and miserable withdrawals, without any of the regulations that surround other opioid drugs. We let you know when newer variants like MGM-15 and MGM-16 came out and how deceptive marketing for all of this can be. We continue to do research in partnership with Johns Hopkins University to increase understanding and awareness around 7OH.
Well, we are now happy to report that the federal government is taking action.
As of July 2026, the Drug Enforcement Administration [DEA] started moving 7OH and related products toward a level of federal regulation on par with heroin or MDMA.1 This is not something that can be done overnight, so we’re going to look at the process, likely timelines, and what this means for consumers, especially those who are most vulnerable to addiction.
First, we’ll have a brief refresher on 7OH and how it fits into the broader picture of addictive substances.
What Is 7OH (7-Hydroxymitragynine)?
7OH is a naturally occurring molecule found in the kratom plant, but it only shows up in tiny amounts. 7OH hits the same receptors as opioid drugs, and users have observed that when they take enough kratom, it can feel like an opiate. This is one of the reasons kratom can pose risks of addiction, especially as it becomes more purified, such as in powder form. There is still debate about how much of a threat kratom really poses.
The problem has become that manufacturers have started extracting, purifying, and concentrating 7OH, then selling it as tablets, gummies, “energy shots,” powders, etc.2 They market these drugs as being all-natural derivatives, but they are really a whole new class of opioids. This puts unsuspecting consumers at high danger of getting hooked on something that has been legal, largely unregulated, and easily available.
The FDA describes concentrated 7OH products as novel potent opioid products and distinguishes them from natural kratom leaf. The agency has also warned consumers that 7OH products have not been proven safe or effective for any medical use.
7OH withdrawal can include symptoms that make stopping difficult without support. The FDA has received reports involving withdrawal symptoms such as restlessness, body aches, fatigue, irritability, insomnia, and cold sweats.
We initially saw clients coming to our program with 7OH as a “side drug” that they added to their mix of intoxicants. Now we are seeing a growing number of clients come to us for help for 7OH as a primary problem.
How Federal Law Is Changing Around 7OH (And How It Isn’t)
About a year ago, in July 2025, the FDA (U.S. Food and Drug Administration) said that 7OH products should be classified as Schedule I substances.3 This means the FDA doesn’t see any practical or medical benefits for these products and the high concentrations of 7OH contained in them.
The catch is, the FDA doesn’t have the power to make 7OH a Schedule I drug; they can only recommend what they think should happen. The DEA has to pick the ball up from there.
What the DEA did in July of this year was designate any substance containing 7OH above a minimum threshold to temporarily be listed as a Schedule I drug. The DEA used a separate order to also give temporary Schedule I status to MGM-15 (a variation on 7OH) and MGM-16 (a synthetic derivative of 7OH), both of which are highly addictive like 7OH. They also added MP, another mitragynine variation that is gaining traction in the marketplace. It’s notable that MGM-15, MGM-16, and MP are not naturally found in the kratom plant. Nonetheless, all three are commonly sold to the public as kratom derivatives or extracts.
Both the FDA and DEA were clear about one thing: this is not a ban on natural kratom products. The recommendations and regulations all specify that they only apply to products with 7OH levels far above what is found naturally in the kratom plant.
What Happens Next With 7OH and Schedule I?
The DEA action means they are moving to ban 7OH, MGM-15, MGM-16, and MP, but it’s not forever. For the next two years, these products will be treated as dangerous substances with no medical or other redeeming value. During that time, researchers affiliated with the U.S. Department of Health and Human Services [HHS] (mostly the FDA, which is part of HHS) are expected to conduct a wide range of research. They will work to determine if 7OH and the other banned substances are in fact without any use, how dangerous they are, how much potential they have for abuse and addiction, etc.
If the FDA finds that there is some legitimate use for 7OH, they can change the recommendation to another level of scheduling, which goes from I-V, with higher numbers generally meaning less restriction. One of the other scheduling designations would mean that the substances would still require rules and oversight but would no longer be completely illegal.
It’s possible, on the other hand, that the HHS/FDA research will indicate that 7OH and the others should be put permanently in Schedule I. If it’s headed that way but more time is needed, then the temporary ban can be extended for one more year, giving three years in total to make the case.
Ironically, having 7OH and the others on temporary Schedule I status can make it harder to do the necessary research to get a final answer. This is because the federal regulations surrounding Schedule I drugs can be very strict. Federal regulators are working to cut through some of these restrictions when research is done for scheduling purposes, but it’s still not easy.
How Windmill Wellness Ranch Is Helping With 7OH
At Windmill Wellness Ranch, we have been helping people face 7OH and its addictive variations since it first started to show up in our clients. That’s why this is more than a headline in the news to us. This is a real problem facing the real people who come to us for help.
We have been seeing an increasing number of people who may have been getting by using 7OH or trying to hide how bad it has gotten for them. They aren’t sure what they are going to do next. They can see it’s a problem, but it’s no longer available, and the idea of going without 7OH can be scary when the withdrawals are so strong.
If this sounds like you, it may be tempting to stock up with whatever you can find or, even worse, see if there is some other poorly understood substance you can take to get by.
Instead, this can be a golden opportunity to finally get help.
At Windmill, we are on the cutting edge of treatment for kratom, 7OH, and its variations, helping to create a safe way to help people detox from 7OH. We continue to work with Johns Hopkins University to advance research in the field.
We understand how hard it can be to get off of 7OH and its relatives. Many people find it as hard as any opioid drug. We can help.
We don’t just help people understand and address drug use; we also help them navigate underlying mental health concerns, along with teaching practical techniques to stay sober and live a great life.
We also include families in our treatment, because the more support someone has, the better their chances of recovery.
Every day, we see that when people believe they can recover and feel good about themselves, they are much more likely to find hope and healing. We specialize in compassionate, evidence-based treatment for both addiction and trauma, helping individuals and families rebuild stability and hope. If you or someone you love needs support, we are here. Call 830-223-2055 or contact us online to take the first step toward healing.
References
- DEA. (2026). DEA to temporarily schedule 7-OH and related substances to protect public safety. Retrieved from: https://www.dea.gov/press-releases/2026/07/01/dea-temporarily-schedule-7-oh-and-related-substances-protect-public
- Alsbrook, S., Pro, G., & Koturbash, I. (2025). From kratom to 7-hydroxymitragynine: evolution of a natural remedy into a public-health threat. Pharmaceutical biology, 63(1), 896-911.
- FDA. (2025). FDA takes steps to restrict 7-OH opioid products threatening American consumers. Retrieved from: https://www.fda.gov/news-events/press-announcements/fda-takes-steps-restrict-7-oh-opioid-products-threatening-american-consumers
Frequently Asked Questions About 7OH and Schedule I
Is 7OH now a Schedule I controlled substance?
It is moving in that direction, but this is a lengthy process. The DEA has taken the first steps by moving 7OH toward Schedule I status for a two-year period, during which research will be done to see if it will remain Schedule I or be moved into a different scheduling classification.
Is the federal government banning kratom?
No, they are not. Both the DEA and FDA went out of their way to clarify that they are not trying to ban kratom that contains only trace amounts of 7OH.
What are MGM-15 and MGM-16?
MGM-15 and MGM-16 are derivatives related to 7OH, with MGM-16 being completely synthetic. Unlike 7OH, these substances don’t show up naturally in kratom at all.
Can you become addicted to 7OH?
Yes, you can. Research shows that 7OH produces quick tolerance, compulsive use, and very uncomfortable withdrawals. These are all very similar to opioids like fentanyl and heroin.
Can 7OH withdrawal be treated?
Yes, and we’ve been doing it since it started showing up in our clients. We’ve worked with top researchers to develop a detox protocol for 7OH and related substances. Anyone experiencing significant withdrawal or unable to stop using 7OH should seek professional medical and addiction-treatment guidance.
